What are the risks associated with the product?
Olumiant (Baricitinib)
Status:
Open Feb 20, 2025 - 12:40 PM
1answer
Answer
Feb 20, 2025 - 12:40 PM
Risks include serious infections, mortality, malignancy, major adverse cardiovascular events (MACE), and thrombosis. Understanding these risks is crucial for informed decision-making and enables proactive monitoring to minimize potential adverse outcomes.
View More Product Details
Olumiant (Baricitinib)
Olumiant is used to treat rheumatoid arthritis and works by blocking inflammation that causes symptoms of rheumatoid arthritis. Buy Olumiant at Canada Pharmacy
View Details
View all Olumiant (Baricitinib) Questions & Answers
